Axsome Therapeutics (AXSM) EBIT Growth (1y) (2016 - 2026)
Powered by 
Analysis
Axsome Therapeutics (AXSM) EBIT Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 145.20% |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 10.14% |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 269.85% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 1,528.74% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -36.55% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 99.51% |
| 10 | Axsome Therapeutics | 10.72 Bn | 10.40 Bn | 204.81 Mn | -35.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.22% |
| Mar 31, 2026 | -11.19% |
| Dec 31, 2025 | 62.88% |
| Sep 30, 2025 | 26.37% |
| Jun 30, 2025 | 52.96% |
| Mar 31, 2025 | 15.30% |
| Dec 31, 2024 | 26.11% |
| Sep 30, 2024 | -0.81% |
| Jun 30, 2024 | -19.97% |
| Mar 31, 2024 | -955.46% |
| Dec 31, 2023 | -64.01% |
| Sep 30, 2023 | -46.47% |
| Jun 30, 2023 | -66.04% |
| Mar 31, 2023 | 83.35% |
| Dec 31, 2022 | -83.75% |
| Sep 30, 2022 | -26.95% |
| Jun 30, 2022 | -27.01% |
| Mar 31, 2022 | -37.51% |
| Dec 31, 2021 | -17.53% |
| Sep 30, 2021 | -58.13% |